Administrative/Regulatory
Jun. 12, 2012
POM persuades FTC to apply lower standard, loses anyways
The ALJ's order found that double-blind, randomized clinical trials were not necessary for claims of the type that POM made. By Guinevere Jobson of Fenwick & West LLP
On May 17, the Federal Trade Commission issued an Initial Decision in the Matter of POM Wonderful LLC and Roll Global LLC, FTC File No. 082-3122 (May 21, 2012), finding that POM violated federal advertising laws by making deceptive disease prevention and treatment claims in national publications, on Internet sites, newsletters and other advertising materials.
According to Administrative Law Judge D. Michael Chappell, reasonable cons...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In